|
Privacy Policy
1. Property rights
The material published on this page, including, but not exclusive restricted to design, text, sound recordings and pictures are properties of the MetrioPharm AG, unless otherwise expressly states. The Copyrights for all material on that page are owned by the MetrioPharm AG, unless otherwise expressly states. For users the material on that page is for free consultation but demanded the acceptance of the MetrioPharm AG in the case of copy, written or electronic form, or publication of the whole material or parts of them, respectively.
No part of this page accords any licence or user rights of pictures, trademarks or logos etc. The download or copy from that page no assigned the titles of software or stuff on or from that page. All copyrights and trademark rights on material at this page are owned by the MetrioPharm AG which will enforce the concerning rights according to the applicable law.
2. Content and material on this page
The informations on this page, the material as well as the conditions for entrance and use can be changed without advance notice. The products and services are not available in all geographic territories. It depends on the local legal or regulatory requirements if the investor has the right to a specific product or service. The possible described services, stocks and financial instruments are not available and applicable for all investors.
The expressions of opinion on this website are exclusively from the authors within the scope of their duties and can be changed without advance notice anytime. The MetrioPharm AG or their contractual partners are authorized to retire or change informations and products or services described on this page anytime. All informations marked with a calendar date are exclusively published for that calendar date. There are no obligations or responsibility to update or correct such informations. The MetrioPharm AG reserves the right to revoke certain or all offers on that page without advance notice. The data on that page neither are decision guidances for legal, capital or other questions of advice nor should come to investment or miscellaneous decisions on the basis of these data.
3. Disclaimer
In no way, neither the MetrioPharm AG nor their contractual partners are liable for all types of losses or disadvantages, (without restrictions) embedded are direct, special, indirect or subsequent damages which can occur from or in the coherence with the access to use, service or queries of the website or with the linkage to other websites even if the MetrioPharm AG was invited to the possibilities of such disadvantages or losses. Some statutory regulations are not allow restrictions of the guarantees, the exclusion or the containment of defined disadvantages or the exclusion from defined implicit guarantees. In such cases the disclaimers and restrictions have no application. In addition to your other authorizations you will award certain rights with that guarantee, in dependence of the respective legal order. The MetrioPharm AG does not assume the guarantee for the allocated data or views, neither explicit nor implicit. Furthermore, the MetrioPharm AG cannot give the assurance or guarantee or assume the liability, that the offers on this page are achieve all user requirements, notably in view of the failure-free operation, the punctuality, the security or the error-free data transfer.
4. No commendation and request for supply of a service respectively
The provided data are attend for information only and are not an investment recommendation or an investment advice. Please notice that the informations on this page display no legal, fiscal or any other advice.
5. Performance
The future performance of the invested capital cannot be derived from the past market trend, that means the investment value can be increase or decrease. In no way, the performance of an investment in the past is a guarantee for future events. The value of an investment can be subject to fluctuations and possibly the investors will not get back the whole invested amount. Changes in currency exchange rates can boost the value of an investment or decrease it.
6. Observation
Please note, that all user activities will registered and analysed for security-,marketing- and system-observation purposes among other things.
7. Spamming
The MetrioPharm AG does not condone "spamming". Spamming is defined as sending unsolicited e-mails, usually of a commercial nature, in large numbers and repeatedly to individuals with whom the sender has had no previous contact or who have declined to receive such communications. In contrast, where the MetrioPharm AG believes that certain product, technical, or other information is of importance to you it reserves the right to inform you by e-mail whilst giving you the choice of opting out of such service.
8. External websites
This Privacy Policy applies only to the MetrioPharm AG website to the exclusion of third-party websites. The MetrioPharm AG may provide links to other websites, which we believe, may be of interest to our visitors/investors. The MetrioPharm AG has no control about the content of these external websites and not assume del credere liability or guarantee for the content of these websites, including correctness, completeness, steadiness or eligibility for specific purposes. Furthermore, the MetrioPharm AG neither guarantees that accrue copyrights or rights to trade mark or miscellaneous impinge upon rights of a third-party from these websites or their content nor that these websites and their content are free of viruses or other infections. For the authenticity of the documents in the internet no guarantee is given. Indeed, the MetrioPharm AG provides links to such external websites but declines any liability for their content.
9. Confidentiality
We would like to point out that during the use of this website the data traffic occurs across an open network, which is also amenable to third-parties. The data traffic is transacted regularly also across foreign networks even if the sender and the receiver are located in the same country. This circumstance may allow conclusions for third-parties that they have an access to the MetrioPharm AG-Homepage.
|